← back to search

Ashani T. Weeraratna

Johns Hopkins University · US
Area of research
Oncology · Molecular Biology
Research interest
Research interests include Pancreatic and Hepatic Oncology Research, Melanoma and MAPK Pathways, Immunotherapy and Immune Responses, and Cancer Immunotherapy and Biomarkers.
h-index
62
citations
18,078
works
654
NIH funding
primary concept
Biology
email

Recent publications

Author Correction: Stromal changes in the aged lung induce an emergence from melanoma dormancy
Nature 2025cited by 3position: lastdoi
Embracing cancer complexity: Hallmarks of systemic disease
Cell 2024cited by 439position: middledoi
Fibroblasts in the Aged Pancreas Drive Pancreatic Cancer Progression
Cancer Research 2024cited by 28position: lastdoi
Cell state dependent effects of Bmal1 on melanoma immunity and tumorigenicity
Nature Communications 2024cited by 21position: middledoi
Aged fibroblast-derived extracellular vesicles promote angiogenesis in melanoma
Cell Reports 2024cited by 13position: lastdoi
Fibroblasts in cancer: Unity in heterogeneity
Cell 2023cited by 456position: lastdoi
Diverse clonal fates emerge upon drug treatment of homogeneous cancer cells
Nature 2023cited by 175position: middledoi
Stromal changes in the aged lung induce an emergence from melanoma dormancy
Nature 2022cited by 175position: lastdoi
Feedback between mechanosensitive signaling and active forces governs endothelial junction integrity
Nature Communications 2022cited by 48position: middledoi
Abstract 3638: Age-related changes in pancreatic fibroblasts promote growth and progression of pancreatic cancer
Cancer Research 2022cited by 0position: lastdoi
Melanoma models for the next generation of therapies
Cancer Cell 2021cited by 226position: middledoi
The State of Melanoma: Emergent Challenges and Opportunities
Clinical Cancer Research 2021cited by 107position: middledoi
A framework for advancing our understanding of cancer-associated fibroblasts
Nature reviews. Cancer 2020cited by 3,711position: middledoi
Changes in Aged Fibroblast Lipid Metabolism Induce Age-Dependent Melanoma Cell Resistance to Targeted Therapy via the Fatty Acid Transporter FATP2
Cancer Discovery 2020cited by 150position: lastdoi
Deconstructing tumor heterogeneity: the stromal perspective
Oncotarget 2020cited by 42position: middledoi
How the ageing microenvironment influences tumour progression
Nature reviews. Cancer 2019cited by 838position: lastdoi
Polyunsaturated Fatty Acids from Astrocytes Activate PPARγ Signaling in Cancer Cells to Promote Brain Metastasis
Cancer Discovery 2019cited by 183position: middledoi
Age Correlates with Response to Anti-PD1, Reflecting Age-Related Differences in Intratumoral Effector and Regulatory T-Cell Populations
Clinical Cancer Research 2018cited by 360position: lastdoi
Acid Suspends the Circadian Clock in Hypoxia through Inhibition of mTOR
Cell 2018cited by 223position: middledoi
Age-Related Changes in HAPLN1 Increase Lymphatic Permeability and Affect Routes of Melanoma Metastasis
Cancer Discovery 2018cited by 145position: lastdoi
Cancer-Associated Fibroblasts Neutralize the Anti-tumor Effect of CSF1 Receptor Blockade by Inducing PMN-MDSC Infiltration of Tumors
Cancer Cell 2017cited by 643position: middledoi
Modeling the two-way feedback between contractility and matrix realignment reveals a nonlinear mode of cancer cell invasion
Proceedings of the National Academy of Sciences 2017cited by 204position: middledoi
RETRACTED ARTICLE: sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance
Nature 2016cited by 390position: lastdoi
Targeting mitochondrial biogenesis to overcome drug resistance to MAPK inhibitors
Journal of Clinical Investigation 2016cited by 299position: middledoi
Response to Programmed Cell Death-1 Blockade in a Murine Melanoma Syngeneic Model Requires Costimulation, CD4, and CD8 T Cells
Cancer Immunology Research 2016cited by 153position: middledoi
The state of melanoma: challenges and opportunities
Pigment Cell & Melanoma Research 2016cited by 128position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Mitchell E. Fane · The Wistar Institute8 papers (2018–2025)Yash Chhabra · Sam Higginbottom Institute of Agriculture6 papers (2022–2025)Marie R. Webster · Thomas Jefferson University5 papers (2017–2025)Daniel J. Zabransky · Convergence5 papers (2022–2025)Gretchen M. Alicea · Johns Hopkins University5 papers (2018–2025)Meenhard Herlyn · The Wistar Institute5 papers (2019–2025)Brett L. Ecker · Northwestern University5 papers (2018–2025)Laura Hüser · Bloomberg (United States)4 papers (2022–2025)Xiaowei Xu · Wannan Medical College4 papers (2018–2025)Andrew V. Kossenkov · University of Pittsburgh4 papers (2020–2025)Stephen M. Douglass · Johns Hopkins University4 papers (2018–2025)David W. Speicher · The Wistar Institute4 papers (2020–2025)Elizabeth M. Jaffee · NYU Langone Health4 papers (2022–2025)Hsin‐Yao Tang · The Wistar Institute4 papers (2020–2025)Vito W. Rebecca · Johns Hopkins University3 papers (2020–2025)Gloria E. Marino · Johns Hopkins Medicine3 papers (2018–2025) · 3 papers (2018–2025)Rebekah Brooks · University of Alabama at Birmingham2 papers (2018–2024)Wei Xu · Peking University2 papers (2022–2025)Zachary T. Schug · The Wistar Institute2 papers (2019–2020)